Clinical Study Evaluating the Anticancer Effect of Pentoxiphylline in Patients With Metastatic Colorectal Cancer

NCT06115174 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Carcinoma

Interventions

DRUG: Pentoxifylline
RADIATION: FOLFOX
RADIATION: XELOX
DRUG: Monoclonal antibodies (target therapy)

Sponsor

Tanta University